Primary cutaneous large B-cell non-Hodgkin lymphoma in first-degree relatives

Biomed Pharmacother. 2012 Sep;66(6):425-7. doi: 10.1016/j.biopha.2012.06.006. Epub 2012 Jun 29.

Abstract

Primary cutaneous non-Hodgkin's lymphoma is a heterogeneous group of lymphoproliferative disorders characterized by indolent course, virtually exclusive skin involvement and the absence of systemic disease. We present two brothers, whose mother died of gastric diffuse large B-cell lymphoma, in whom in a period of 4 years primary cutaneous large B-cell non-Hodgkin lymphoma of the skin of the head was diagnosed. They were treated with immunochemotherapy according to R-CHOP protocol (rituximab and adriblastine, cyclophosphamide, oncovine and prednisone) achieving a complete remission. The possible etiological mechanism of this familial lymphoma occurrence is discussed.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Family Health*
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Lymphoma, Primary Cutaneous Anaplastic Large Cell / drug therapy*
  • Male
  • Prednisone / therapeutic use
  • Remission Induction
  • Rituximab
  • Scalp*
  • Serbia
  • Siblings
  • Skin Neoplasms / drug therapy*
  • Vincristine / therapeutic use

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • R-CHOP protocol
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone